Methods Database for Empower CDS with Pistoia Alliance and Agilent

In pharmaceutical R&D, data reproducibility remains a persistent and costly challenge. Many analytical methods are still documented manually or stored in proprietary formats, making it difficult to ensure consistency, traceability, and reuse across laboratories and organizations. This webinar explores how the Methods Database project—developed in collaboration with the Pistoia Alliance and Agilent Technologies—is addressing these challenges by transforming how analytical methods are created, shared, and executed.

Moving from Text-Based Methods to Digital Standards

Traditional analytical methods, such as HPLC workflows, are often captured as text-based instructions that are difficult to standardize, transfer, or automate. In this session, CEO and Founder of ZONTAL, Wolfgang Colsman, demonstrates how the Methods Database introduces a semantic data model built on Allotrope standards to convert these methods into fully digitized, machine-readable instruction sets.

By structuring methods as data, organizations can preserve critical parameters, ensure reproducibility, and enable seamless transfer between systems without loss of context. This shift lays the foundation for improved interoperability, reduced manual error, and greater efficiency across the lab ecosystem.

Enabling Interoperability Across Systems and Organizations

A key focus of the Methods Database is enabling true interoperability between instruments, vendors, and organizations. Through the use of standardized data models and adapters, methods can be transferred from one system to another—regardless of vendor—while maintaining integrity and execution readiness.

This capability supports not only internal collaboration but also external partnerships, such as contract research organizations (CROs), where consistent method execution is critical. By enabling digital business-to-business method transfer, the project helps eliminate variability and ensures that analytical workflows remain consistent across the entire lifecycle.

Connecting Methods, Data, and Results

Beyond digitizing methods, the platform connects method parameters directly with experimental results. This linkage creates a unified data environment where both inputs and outputs are traceable, searchable, and analyzable.

By bringing methods and results together in a single system, organizations can unlock advanced analytics capabilities, including performance monitoring, out-of-specification analysis, and AI-driven insights. This holistic view is essential for improving quality, accelerating decision-making, and enabling continuous optimization in pharmaceutical development.

Advancing Automation and AI-Ready Data Foundations

The Methods Database project represents a critical step toward fully automated and AI-ready laboratories. By standardizing how methods are defined and executed, and by capturing them in structured, machine-readable formats, organizations can move toward closed-loop workflows where data flows seamlessly between systems.

This foundation enables automation of analytical processes, reduces manual intervention, and prepares data for advanced applications such as machine learning and predictive analytics. As digital transformation accelerates across life sciences, the ability to operationalize data at this level becomes a key competitive advantage.